$CODX Up 16% Premarket! 🚀 🔹 Co-Diagnostics is catching momentum as hantavirus headlines put molecular diagnostic names back in focus 🦠 🔹 Company develops PC

$CODX Up 16% Premarket! 🚀 🔹 Co-Diagnostics is catching momentum as hantavirus headlines put molecular diagnostic names back in focus 🦠 🔹 Company develops PCR-based diagnostic testing technology through its patented CoPrimer platform 🧬 🔹 Hantavirus outbreak concerns are driving attention toward…